Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Anti-MS4A4A antibodies and methods of use thereof

Grant US-11667699-B2

United States of America

Anti-MS4A4A antibodies and methods of use thereof

Grant US-11472874-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.